- Reports /
- Hearing Care Devices Market
Hearing Care Devices Market
Hearing Care Devices Market Research Report – Segmented By Product (HEARING AIDS, HEARING IMPLANTS), By Type Of Hearing Loss (CONDUCTIVE HEARING LOSS, SENSORINEURAL HEARING LOSS), By End User (HOSPITALS & CLINICS, HOME-USE, AMBULATORY SURGICAL CENTERS (ASCS)), By Region (NORTH AMERICA, EUROPE, ASIA-PACIFIC, LAMEA) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.
Table of contents
- Executive Summary
- Market Overview
- Industry Analysis
- Market Analysis
- By Product
- By Type Of Hearing Loss
- By End User
- By Region
- North America
- Europe
- Asia-Pacific
- Middle-East & Africa
- Latin America
- Company Analysis
- Competitive Analysis
- Research Methodology
- Appendix
Executive Summary
Hearing Care Devices Market was valued at US $6.87 billion in 2021 and is projected to grow at 5.63% CAGR over the forecast period to reach US $9.53 billion by 2027. Hearing Care Devices Market represented US $0.71 billion opportunity over 2019-2021 and estimated to create US $2.67 billion opportunity in 2027 over 2021.
Hearing Care Devices from Consainsights analyses the Hearing Care Devices Market in the Life Sciences industry over the forecast period to 2027.
Hearing Care Devices research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Hearing Care Devices segmentation includes Product, Type Of Hearing Loss, End User, Region and Geography.
Based on the Product, the Hearing Care Devices analysis covers HEARING AIDS, HEARING IMPLANTS.
In Product segment, HEARING AIDS segment has highest cagr growth of 4.99%.
Based on the Type Of Hearing Loss, the Hearing Care Devices analysis covers CONDUCTIVE HEARING LOSS, SENSORINEURAL HEARING LOSS.
In Type Of Hearing Loss segment, CONDUCTIVE HEARING LOSS segment has highest cagr growth of 4.99%.
Based on the End User, the Hearing Care Devices analysis covers HOSPITALS & CLINICS, HOME-USE, AMBULATORY SURGICAL CENTERS (ASCS).
In End User segment, HOSPITALS & CLINICS segment has highest cagr growth of 4.99%.
Based on the Region, the Hearing Care Devices analysis covers NORTH AMERICA, EUROPE, ASIA-PACIFIC, LAMEA.
In Region segment, NORTH AMERICA segment has highest cagr growth of 4.99%.
Based on the region, the Hearing Care Devices analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include AMERICAN HEARING AIDS, AMPLIFON, COCHLEAR LTD., GN STORE NORD A/S, INTRICON CORPORATION, MED-EL, SIVANTOS PTE. LTD., SONOVA, STARKEY, WIDEX USA, INC., WILLIAM DEMANT HOLDING A/S and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.
Market Overview
Definition & Scope
The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
Currency, Year & Forecast
The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
Product
Introduction
In 2021, HEARING AIDS segment has the highest revenue of US $5.49 billion and is expected to grow at CAGR of 4.99% by 2027 HEARING AIDS segment has highest cagr growth of 4.99%.
HEARING AIDS
HEARING AIDS segment was valued at US $4.92 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $7.63 billion by 2027. HEARING AIDS segment represented US $0.57 billion opportunity over 2019-2021 and estimated to create US $2.14 billion opportunity in 2027 over 2021.
HEARING IMPLANTS
HEARING IMPLANTS segment was valued at US $1.23 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $1.91 billion by 2027. HEARING IMPLANTS segment represented US $0.14 billion opportunity over 2019-2021 and estimated to create US $0.53 billion opportunity in 2027 over 2021.
Type Of Hearing Loss
Introduction
In 2021, CONDUCTIVE HEARING LOSS segment has the highest revenue of US $4.46 billion and is expected to grow at CAGR of 4.99% by 2027 CONDUCTIVE HEARING LOSS segment has highest cagr growth of 4.99%.
CONDUCTIVE HEARING LOSS
CONDUCTIVE HEARING LOSS segment was valued at US $4.00 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $6.20 billion by 2027. CONDUCTIVE HEARING LOSS segment represented US $0.46 billion opportunity over 2019-2021 and estimated to create US $1.74 billion opportunity in 2027 over 2021.
SENSORINEURAL HEARING LOSS
SENSORINEURAL HEARING LOSS segment was valued at US $2.15 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $3.34 billion by 2027. SENSORINEURAL HEARING LOSS segment represented US $0.25 billion opportunity over 2019-2021 and estimated to create US $0.93 billion opportunity in 2027 over 2021.
End User
Introduction
In 2021, HOSPITALS & CLINICS segment has the highest revenue of US $4.07 billion and is expected to grow at CAGR of 4.99% by 2027 HOSPITALS & CLINICS segment has highest cagr growth of 4.99%.
HOSPITALS & CLINICS
HOSPITALS & CLINICS segment was valued at US $3.65 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $5.66 billion by 2027. HOSPITALS & CLINICS segment represented US $0.42 billion opportunity over 2019-2021 and estimated to create US $1.58 billion opportunity in 2027 over 2021.
HOME-USE
HOME-USE segment was valued at US $2.27 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $3.52 billion by 2027. HOME-USE segment represented US $0.26 billion opportunity over 2019-2021 and estimated to create US $0.98 billion opportunity in 2027 over 2021.
AMBULATORY SURGICAL CENTERS (ASCS)
AMBULATORY SURGICAL CENTERS (ASCS) segment was valued at US $0.23 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $0.36 billion by 2027. AMBULATORY SURGICAL CENTERS (ASCS) segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.10 billion opportunity in 2027 over 2021.
Region
Introduction
In 2021, NORTH AMERICA segment has the highest revenue of US $2.63 billion and is expected to grow at CAGR of 4.99% by 2027 NORTH AMERICA segment has highest cagr growth of 4.99%.
NORTH AMERICA
NORTH AMERICA segment was valued at US $2.36 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $3.65 billion by 2027. NORTH AMERICA segment represented US $0.27 billion opportunity over 2019-2021 and estimated to create US $1.02 billion opportunity in 2027 over 2021.
EUROPE
EUROPE segment was valued at US $1.48 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $2.29 billion by 2027. EUROPE segment represented US $0.17 billion opportunity over 2019-2021 and estimated to create US $0.64 billion opportunity in 2027 over 2021.
ASIA-PACIFIC
ASIA-PACIFIC segment was valued at US $1.41 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $2.18 billion by 2027. ASIA-PACIFIC segment represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.61 billion opportunity in 2027 over 2021.
LAMEA
LAMEA segment was valued at US $0.91 billion in 2019 and is projected to grow at 4.99% CAGR over the forecast period to reach US $1.41 billion by 2027. LAMEA segment represented US $0.11 billion opportunity over 2019-2021 and estimated to create US $0.39 billion opportunity in 2027 over 2021.